We are delighted that the pre-print of our recent COVID-19 study titled „A live attenuated vaccine confers superior mucosal and systemic immunity to SARS-CoV-2 variants“ has attracted widespread attention in various public media outlets. We hope to continue engaging with and communicating our scientific findings to the general public. Below you can find some of the press releases relating to our study:
berliner-zeitung.de, tagesspiegel.de, zeit.de, pharmazeutische-zeitung.de, spektrum.de, deutschlandfunk.de, news-medical.net, mdr.de, blick.ch, faz.net
Schreibe einen Kommentar